Clinical Trials
8 trialsNCT00256776 2021-10-18
MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation
European Society for Blood and Marrow Transplantation
Phase 3 Terminated
NCT01470131 2018-12-19
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma
AB Science
Phase 3 Terminated
NCT02489500 2018-09-10
VelRand
Boston Medical Center
Phase 3 Terminated
NCT01002248 2018-02-09
Assessment of Efficacy and Safety of Perifosine, Bortezomib and Dexamethasone in Multiple Myeloma Patients
AEterna Zentaris
Phase 3 Terminated
NCT00574080 2017-11-20
UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide
University of Arkansas
Phase 3 Terminated
NCT00657553 2017-11-20
2007-77
University of Arkansas
Phase 3 Terminated
NCT00522392 2015-06-26
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00573391 2011-08-12
Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2
University of Arkansas
Phase 3 Terminated